PharmaVOICE - 
October 2010
Purchase Issue

In Every Issue
Last Word
Current Challenges in BioScience What are some of the hot [...]
By
Talent Pool
Pharmaceutical POOL Timothy HAYES Bayer Adds Global Business Development Oversight [...]
By
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: [...]
By
What’s New
New Healthcare-related Products, Services, and Companies Featured Briefs: Parexel’s Solution [...]
By
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: [...]
By
UpFront
Awards Sanofi-Aventis Receives HBA’s ACE Award The Healthcare Businesswomen’s Association [...]
By
Letter from the Editor
The appeal of the iPad… It’s hard not to be [...]
By

Taren Grom, Editor

On The Cover

Effective Global Teams Are Aligned, Not Built
Trust, understanding, common goals and perceptions, speaking the same language —­literally and figuratively — all sound like the ingredients for a ­successful marriage. The same factors that are inherent in any successful ­relationship must be present among the ­members of global ­cross-functional teams, or the results are just as disastrous: missed deadlines, delayed drugs to [...]
By

Robin Robinson

Features

SHOWCASE FEATURE: Managing Data: The Core of Clinical Research
Data are the lifeblood of clinical research. A plethora of new technologies have become available over the last decade to help pharmaceutical companies address some of the challenges related to data management. Companies have made a commitment to EDC and e-clinical platforms, and newer technologies, such as electronic health records will continue to evolve. Even [...]
By
Women in Science: A Work in Progress
It’s a fact that gender discrepancy in the field of science exists. It’s a fact that changes in legislation, academic policies, and an overall increased awareness of gender bias are improving a woman’s chances of succeeding in all the STEM (science, technology, engineering, and math) fields. However, it is also a fact that a woman [...]
By

Robin Robinson

Tomorrow’s MSL: Specialist or Generalist?
MSLs have been around for 40 years, and with the evolution of technology, increased regulations and government scrutiny, and the squeeze of the declining salesforce, today the role may be even more crucial to the drug-development and commercialization process. According to Robin Winter-Sperry, M.D., president and CEO of Scientific Advantage and MSL Advantage, MSLs are [...]
By

Robin Robinson

Pharma is Taking Its Byte of the Apple
Sales reps have been using mobile CRM applications on their smart phones and laptops for years, but the larger screen and “wow” factor of the iPad may bring additional benefits and functions to bear. Novelty of iPad Increases Mobile Technology Demand With the recent emergence of more sophisticated tools, such as the iPad, which are [...]
By

Robin Robinson

Orphan Drugs: Opportunity in Rare Diseases
Rare diseases could be big business for the bio/pharmaceutical industry. A changing landscape in the healthcare and pharmaceutical industries is facilitating efforts to enhance the incentives for pursuing research and development for rare diseases. The development of orphan drugs traditionally was pursued by small biotechnology companies, but that is beginning to shift. The blockbuster model [...]
By

Denise Myshko

FEEDBACK